mTORC1 activity is essential for erythropoiesis and B cell lineage commitment

Natasha Malik1, Karen M Dunn1, Jennifer Cassels1

  • 1Institute of Cancer Sciences, College of Medicine, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.

Scientific Reports
|November 16, 2019
PubMed

Insights

Mechanistic target of rapamycin complex 1 (mTORC1) is crucial for blood cell development. Inhibiting mTORC1 disrupts red blood cell and B cell production, highlighting its essential role in hematopoietic lineage commitment.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Hematology

Background:

  • The mechanistic target of rapamycin (mTOR) pathway, specifically mTOR complex 1 (mTORC1), is a key regulator of cellular functions including protein synthesis, cell proliferation, and apoptosis.
  • Understanding the role of mTORC1 in hematopoietic stem cell differentiation is critical for comprehending blood cell development and potential therapeutic interventions.

Purpose of the Study:

  • To investigate the specific role of mTORC1 in hematopoietic lineage commitment using genetic knockout mouse models and cell lines.
  • To delineate the impact of mTORC1 deficiency on erythropoiesis and B lymphopoiesis.

Main Methods:

  • Utilized Mx1-cre and Vav-cre expression systems to generate Raptor-deficient (mTORC1) mouse models.
  • Assessed developmental and cellular phenotypes in knockout mice, including survival rates, erythropoiesis, and B cell development.
  • Confirmed findings using K562 cell differentiation assays and mTOR inhibitors in vitro.
  • Investigated the opposing role of mTORC2 by analyzing Rictor-deficient progenitor cells.

Main Results:

  • Vav-cre+Raptorfl/fl mice exhibited embryonic lethality due to severe aberrations in erythropoiesis, with an arrest at the megakaryocyte-erythrocyte progenitor stage.
  • Raptor-deficient mice showed a significant block in B cell lineage commitment.
  • These defects were recapitulated in adult Mx1-cre+Raptorfl/fl mice upon induction, confirming the essential role of mTORC1 in erythrocyte and B lineage commitment.
  • Expression of key regulators GATA1, GATA2, and PAX5 was dysregulated in the absence of mTORC1.
  • In vitro studies demonstrated that mTOR inhibition reduced K562 cell differentiation towards red blood cells (RBCs).
  • Conversely, Rictor deficiency (mTORC2) led to enhanced RBC colony formation, indicating an opposing role for mTORC2.

Conclusions:

  • mTORC1 is critically important for regulating hematopoietic cell lineage commitment, particularly for erythropoiesis and B lymphopoiesis.
  • mTORC1 signaling is essential for the proper development of red blood cells and B cells.
  • mTORC2 appears to have an antagonistic role in RBC development compared to mTORC1.

Related Concept Videos

Lineage Commitment01:21

Lineage Commitment

Commitment is the  process whereby stem cells:
4.0K
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
15.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
5.6K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.8K
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
8.4K